Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Ljungman

Showing results (21-30 of 320) with videos related to

Pageof 32
Sort By:
Anticancer Research|April 19, 2011
Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patientsTina Dalianis, Per Ljungman
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 6, 2007
Human herpesvirus-6 infection in solid organ and stem cell transplant recipientsPer Ljungman, Nina Singh
Haematologica|July 26, 2007
Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donorsPer Ljungman, Ronald Brandan
Blood|March 21, 2009
How we treat cytomegalovirus in hematopoietic cell transplant recipientsMichael Boeckh, Per Ljungman
British Journal of Haematology|October 23, 2015
The challenge of antibiotic resistance in haematology patientsOla Blennow, Per Ljungman
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2010
Update to vaccination guidelinesPer Ljungman, Trudy N Small,
Hematology/Oncology Clinics of North America|January 18, 2011
Cytomegalovirus in hematopoietic stem cell transplant recipientsPer Ljungman, Morgan Hakki, Michael Boeckh
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Definitions of cytomegalovirus infection and disease in transplant recipientsPer Ljungman, Paul Griffiths, Carlos Paya
Bone Marrow Transplantation|October 22, 2025
Changing scenario in prevention and management of CMV infections in pediatric hematopoietic stem cell transplant patientsFederica Galaverna, Jan Styczynski, Per Ljungman
Blood|March 24, 2020
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantationHermann Einsele, Per Ljungman, Michael Boeckh
Pageof 32

Showing results (21-30 of 320) with videos related to

Sort By:
Pageof 32
Anticancer Research|April 19, 2011
Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patientsTina Dalianis, Per Ljungman
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 6, 2007
Human herpesvirus-6 infection in solid organ and stem cell transplant recipientsPer Ljungman, Nina Singh
Haematologica|July 26, 2007
Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donorsPer Ljungman, Ronald Brandan
Blood|March 21, 2009
How we treat cytomegalovirus in hematopoietic cell transplant recipientsMichael Boeckh, Per Ljungman
British Journal of Haematology|October 23, 2015
The challenge of antibiotic resistance in haematology patientsOla Blennow, Per Ljungman
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2010
Update to vaccination guidelinesPer Ljungman, Trudy N Small,
Hematology/Oncology Clinics of North America|January 18, 2011
Cytomegalovirus in hematopoietic stem cell transplant recipientsPer Ljungman, Morgan Hakki, Michael Boeckh
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Definitions of cytomegalovirus infection and disease in transplant recipientsPer Ljungman, Paul Griffiths, Carlos Paya
Bone Marrow Transplantation|October 22, 2025
Changing scenario in prevention and management of CMV infections in pediatric hematopoietic stem cell transplant patientsFederica Galaverna, Jan Styczynski, Per Ljungman
Blood|March 24, 2020
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantationHermann Einsele, Per Ljungman, Michael Boeckh
Pageof 32